Ote, Evelyn B.

HRN: 23-80-54  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/04/2023
CEFUROXIME 750MG (VIAL)
12/04/2023
12/11/2023
IV
750mg
TID
Skin Tissue Infection
Rejected 

 Indication:  Prophylaxis    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: Non-compliant To Guidelines